Advertisement

Topics

Latest "Debiopharm Group" News Stories

17:06 EDT 20th October 2018 | BioPortfolio

Here are the most relevant search results for "Debiopharm Group" found in our extensive news archives from over 250 global news sources.

More Information about Debiopharm Group on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Debiopharm Group for you to read. Along with our medical data and news we also list Debiopharm Group Clinical Trials, which are updated daily. BioPortfolio also has a large database of Debiopharm Group Companies for you to search.

Showing "Debiopharm Group" News Articles 1–25 of 7,900+

Relevant

Debiopharm Strengthens Compliance, Clinical Trial Oversight With Veeva Vault eTMF

Clinical Informatics News Brief | Veeva Systems announced that Debiopharm selected Veeva Vault eTMF to improve oversight across its trial master file processes and work closely with contract research organizations by collaborating on a single, cloud-based application.    


Debiopharm International SA Strengthens Compliance and Clinical Trial Oversight with Veeva Vault eTMF

Global biopharmaceutical company enables real-time inspection readiness and improves CRO collaboration Veeva Systems (NYSE: VEEV) announced today that

Debiopharm Group Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13082018] Prices from USD $250

SummaryDebiopharm Group Debiopharm is a biopharmaceutical company that develops biologics and small molecule drug candidates. The company's product portfolio includes eloxatin, elplat, dacotin, dacplat, decapeptyl, neo decapeptyl, trelstar, pamorelin, salvacyl and moapar, among others. It also offers services such as clinical development, manufacturing and quality assurance, regulatory services an...


Debiopharm Group Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13042018] Prices from USD $250

SummaryDebiopharm Group Debiopharm is a pharmaceutical company that develops biologics and small molecule drug candidates targeted at unmet medical needs. The company provides products portfolio such as eloxatin, elplat, dacotin, dacplat, decapeptyl, neo decapeptyl, trelstar, pamorelin, salvacyl and moapar, among others. It also provides services such as clinical development, manufacturing and qua...

PTV News: Jan 8, 2010

Top stories on January 8th, 2010: Huge potential: Vivus obesity drug cuts sleep apnea too Lundbeck investigated by EU over generic claims Second stab: Debiopharm to develop Pfizer failure Cyclacel's changing fortunes Action Shares Risk averse: Why Australian investors are still shy of biotech

Debiopharm Innovation Fund SA Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13042018] Prices from USD $250

SummaryDebiopharm Innovation Fund SA Debiopharm Diagnostics, formerly Debiopharm Diagnostics SA, a subsidiary of Debiopharm Group, is a patient care investment company that offers drug investments and development stage diagnostics solutions. The company offers investments for drugs on cancer severity and recurrence, omics and clinical big data management, point of care turnkey Dx platforms, bloodb...

Debiopharm International SA Medical Equipment Deals and Alliances Profile [Report Updated: 18072018] Prices from USD $250

SummaryDebiopharm International SA Debiopharm, a subsidiary of Debiopharm Group is a biopharmaceutical company that develops prescription drugs. The company offers a range of licensing and drug development solutions. It evaluates, searches, and inlicenses promising drug candidates for development. Debiopharm's products includes decapeptyl, eloxatin, pamorelin, trelstar, moapar and salvacyl among o...

Debiopharm International SA Medical Equipment Deals and Alliances Profile [Report Updated: 16052018] Prices from USD $250

SummaryDebiopharm International SA Debiopharm, a subsidiary of Debiopharm Group is a biopharmaceutical company that develops prescription drugs. The company offers a range of licensing and drug development solutions. It evaluates, searches, and inlicenses promising drug candidates for development. Debiopharm's products includes decapeptyl, eloxatin, pamorelin, trelstar, moapar and salvacyl among o...

Debiopharm International SA Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12042018] Prices from USD $250

SummaryDebiopharm International SA Debiopharm, a subsidiary of Debiopharm Group is a biopharmaceutical company that develops prescription drugs. The company offers a range of licensing and drug development solutions. It evaluates, searches, and inlicenses promising drug candidates for development. Debiopharm's products includes decapeptyl, eloxatin, pamorelin, trelstar, moapar and salvacyl among o...

Unlimited Group appoints group managing director

Michael Richards joins the group from VCCP

Probably Relevant

Delek Group Announces Consolidated Second Quarter 2018 Results

TEL AVIV, Israel, Aug. 30, 2018 /PRNewswire/ -- Delek Group Ltd. (TASE: DLEKG) (OTC: DGRLY) (hereinafter: "Delek Group" or "The Group") announced today its results Read more...

Zur Rose Group takes over e-commerce activities of medpex, Germany's third-largest online pharmacy

EQS Group-News: Zur Rose Group AG / Key word(s): Takeover 18.10.2018 / 06:50 Under the following link, you will find the press release on Zur Rose Group's transaction with medpex.   https://zurrosegroup.com/websites/zurrosegroup/English/2015/acquisition-medpex.html   End of Corporate News ...

BTG buys Irish med device group Novate

Specialist healthcare group BTG has snapped up med tech group Novate Medical in a deal potentially worth $150 million.

New haematology patient group launched

The launch of a new patient engagement group for those with blood conditions has brought together patients, clinicians and researchers to discuss how to get patient involved in research. A screening of the film People are Messy at the Ultimate Picture Palace followed by a group discussion marked the launch of the Oxford Blood Group, a new local ... Read more

The Stars Group anuncia la oferta privada de 1. ...

The Stars Group Inc. (NASDAQ: TSG) (TSX: TSGI) ('The Stars Group' o 'la compañía') anunció hoy el aumento de tamaño y precio por medio Read more...

Group medical visits fail to improve outcomes in patients with diabetes

Group medical visits — the combination of group self-management education and one-on-one consultations with clinicians — did not improve several medical outcomes in patients with diabetes, according to findings recently published in the Journal of the American Board of Family Medicine.“While diabetes group visits have been evaluated before, most evaluations have been pilots or randomized-con...

EDB Group: Carola Schropp on the Role of EBD Group conferences in partnering and deal making

In this episode of PharmaTelevsion News Review, Fintan Walton discusses the recent BioPharm America conference in Boston with Carola Schropp from the EBD Group. • Role of EBD Group conferences in partnering and deal making • The impact of conferences in actual deal making • EBD Group 's perspective: The state and changes in pharma and biotech industry • EBD Group 's perspective on futu...

#jobs #lifescience CK Group: EHS Manager – Dun Laoghaire

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: CK Group: EHS Manager – Dun Laoghaire . Up to €60 per hour Ltd: CK Group: Jenni Woolley at CK Group is recruiting for an EHS Manager to … Continue reading → Cet article #jobs #lifescience CK Group: EHS Manager – Dun Laoghaire est apparu en premier sur...

A physician’s group disability nightmare

My last operative day was October 15, 2009. My last attempt at getting to understand my group disability policy was on May 10, 2018. I’m a disabled anesthesiologist who lost his career when my left median nerve stopped functioning properly. I had two disability policies, a private and a group. My dealings with these two […]

Die Stars Group kündigt Preis für Public Offering von Stammaktien an

Die Stars Group Inc. (Nasdaq: TSG) (TSX: TSGI) ("die Stars Group" oder "die Gesellschaft") gab heute das Upsizing und Pricing für sein unterzeichnetes Proposed Public Read more...

Gaming Innovation Group Launches GiG Comply and Signs With Mr Green as First Client

STOCKHOLM, Aug. 30, 2018 /PRNewswire/ -- Gaming Innovation Group Inc. (GiG) has signed an agreement with Mr Green, one of the brands of MRG Group Read more...

Sandvik to Acquire Metrology Software Company Metrologic Group

Headquartered in Meylan, France, Metrologic Group is a market leader in agnostic metrology software. In its fiscal year ending in September 2017Metrologic Group Read more...

AbbVie doubles down on cancer project with biotech group Argenx

Biotech group Argenx said on Wednesday U.S. pharma group AbbVie had exercised an exclusive option to develop and commercialize one of its experimental drugs which could lead to payments of up to $625 million.

#jobs #lifescience CK Group: Maintenance Technician – Inverness

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: CK Group: Maintenance Technician – Inverness . £19.67 per hour: CK Group: CK Group are currently working with a leading Medical Device organisation to recruit a Maintenance Technician … Continue reading → Cet article #jobs #lifescience CK Group: Maintenance ...

DGAP-News: Zur Rose Group AG: DocMorris und apo-rot kooperieren (deutsch)

Zur Rose Group AG: DocMorris und apo-rot kooperieren EQS Group-News: Zur Rose Group AG / Schlagwort(e): Kooperation Zur Rose Group AG: DocMorris und apo-rot kooperieren 24.05.2018 / 07:05 --------...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks